Article Versions Notes

Burkart TL, Kraus A, Koller B, Natalucci G, Latal B, Fauchère J-C, Bucher HU, Rüegger CM, For the Swiss EPO Neuroprotection Trial Group. Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter? Children. 2017; 4(6):43. https://doi.org/10.3390/children4060043

Burkart, Tiziana L., Andrea Kraus, Brigitte Koller, Giancarlo Natalucci, Beatrice Latal, Jean-Claude Fauchère, Hans Ulrich Bucher, Christoph M. Rüegger, and For the Swiss EPO Neuroprotection Trial Group. 2017. "Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter?" Children 4, no. 6: 43. https://doi.org/10.3390/children4060043

Burkart, T. L., Kraus, A., Koller, B., Natalucci, G., Latal, B., Fauchère, J.-C., Bucher, H. U., Rüegger, C. M., & For the Swiss EPO Neuroprotection Trial Group. (2017). Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter? Children, 4(6), 43. https://doi.org/10.3390/children4060043